LMLucas Arruda Moita

Lucas Arruda Moita

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lucas Arruda Moita has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Histamine Mediates the Edematogenic Effect of Latex of Plumeria pudica in Mice

    by Mayck Silva Barbosa, Bruna da Silva Souza, Lucas Arruda Moita, Felipe Cardoso de Brito, Ana Clara Silva Sales, Francisca Dayane Soares da Silva, Tino Marcos Lino da Silva, Tarcísio Vieira de Brito, Cleverson Diniz Teixeira de Freitas, André Luiz dos Reis Barbosa, et al.

    HIGHLIGHTS Latex from P. pudica contains molecules with pro (DLPp) and anti-inflammatory activities (LPPp). DLPp pro-inflammatory activity depended on the administered dose and could be inhibited by the LPPp. Pro-inflammatory activity of DLPp is related to histamine-like molecules in the fraction. Antihistaminic drugs can be used to treat inflammation associated with P. pudica latex exposure.

  • Open Access

    Protective effect of proteins extracted from Plumeria pudica latex on ethanol-induced gastric injury in mice

    by Lucas Arruda Moita, Bruna da Silva Souza, Naylla Veras de Moraes Oliveira, Ana Clara Silva Sales, Lucas Eduardo Silva Oliveira, Ana Patrícia de Oliveira, Francisca Beatriz Melo Sousa, Jand-Venes Rolim Medeiros, Jefferson Soares de Oliveira

    Purpose: To evaluate proteins from Plumeria pudica latex (LPPp) for their protective effect against ethanol-induced gastric injury in mice.


  • Open Access

    Desafios atuais para a erradicação hanseníase: do diagnóstico ao tratamento

    by Bruna da Silva Souza, Ana Clara Silva Sales, Lucas Arruda Moita, Gabriella Linhares de Andrade, Francisca Dayane Soares da Silva, Thalis Ferreira de Souza, Matheus Pedrosa de Oliveira

    A hanseníase e uma doença crônica, granulomatosa, de evolução lenta causada pelo Mycobacterium leprae, que afeta pele e sistema nervoso periférico gerando incapacidades físicas. Apesar do uso da multidroga terapia, o número de novos casos ainda se mantém constante em muitos países. A possibilidade da eliminação global da hanseníase tem sido discutida pela OMS e por vários autores, desta forma, o presente trabalho tem como objetivo apresentar os desafios a ainda serem superados em relação ao seu diagnóstico e ao tratamento para que essa meta seja alcançada. Para isto, foram realizadas buscas de arquivos nas bases de dados SCOPUS, PUBMED, SCIELO, Google Acadêmico. Uma vez que o diagnóstico da hanseníase é baseado em alguns sinais clínicos, muitos profissionais têm dificuldade em reconhecer os achados sugestivos da doença. Um dos problemas serem contornados é a ausência de um exame que apresente especificidade e sensibilidade elevada para todas as formas clínicas. O desenvolvimento de um método rápido, sensível e não invasivo mostra-se de grande importância para o diagnóstico definitivo. O diagnóstico precoce é um fator crucial para o controle da doença e que pode prevenir o aparecimento de incapacidades. O tratamento da hanseníase, sua adesão e sua conclusão são essenciais, no entanto, a quantidade de pessoas que aderem a medicação tem sido inconstante. Além disso, a resistência do M. leprae aos fármacos atualmente existentes também se mostra como um obstáculo a ser superado. Dessa forma, muitos são os entraves que permanecem a serem superados para que hanseníase possa ser erradicada no mundo.


  • Open Access

    Estudo de atividades biológicas e aplicações de componentes da planta Plumeria pudica Jacq.: uma prospecção científica e tecnológica com ênfase na atividade antimicrobiana

    by Ana Clara Silva Sales, Lucas Arruda Moita, Bruna da Silva Souza, Thalis Ferreira de Souza, Gabriella Linhares de Andrade, Francisca Dayane Soares da Silva, Jefferson Soares de Oliveira

    In this prospection, the objective was to carry out a study on biological activities and technological applications already described for products from the Plumeria pudica plant, with special emphasis on the possible applications of these substances as antibacterial and antifungal agents. For this, information was obtained on scientific articles in the Scielo, Scopus, Science Direct, Web of Science and PubMed databases, as well as on patent documents in the INPI, USPTO, EPO, WIPO and LATIPAT databases, using keywords and specific boolean operators, always used in the search field relative to the title, abstract and keywords of the study. Thus, it was found that in international databases of scientific articles, there are few published studies involving the species, as well as a relatively low number of patent documents. It is concluded that, in general, in the databases, both scientific production in articles and patent applications are scarce. This demonstrates that there are great opportunities for research involving the description of biological activities and technological applications of compounds from the species.

  • Anti-Inflammatory Agents Produced from Plant Latex

    by Bruna da Silva Souza, Mayck Silva Barbosa, Ana Clara Silva Sales, Lucas Arruda Moita, Naylla Veras de Moraes Oliveira, Jhoana D’aRc Lopes de Sousa, Francisca Dayane Soares da Silva, Jefferson Soares de Oliveira

    Plants have been the main source of molecules for the treatment of diseases over the years. They have been used in traditional medicine based on experience and practice. Many molecules from plant latex have been isolated, identified and tested for pharmacological activities, including reduction of inflammation. This review provides an overview of the latexes released from different plant species and their anti-inflammatory properties. Different in vivo and in vivo assays have been performed trying to confirm this pharmacological potential. Many studies suggest that latexes from plants have therapeutic potential to treat inflammatory diseases and support their traditional medicinal use.

  • Open Access

    Acute and Subchronic Toxicity Assessment of Proteins from Plumeria pudica Latex in Mice

    by Bruna da Silva Souza, Naylla Veras de Moraes Oliveira, Lucas Arruda Moita, Lucas Eduardo Silva Oliveira, Felipe Cardoso de Brito, Felipe Rodolfo Pereira da Silva, Luiz Felipe de Carvalho França, Francisca Beatriz Melo Sousa, Anna Carolina Toledo Cunha Pereira, Gustavo Portela Ferreira, et al.

    Latex proteins extracted from Plumeria pudica (LPPp) have anti-inflammatory activity in different experimental models. Considering this relevant result, we evaluated the toxicological aspects of the treatment of mice with LPPp. Acute and subchronic toxicities were determined by daily intraperitoneal administration of 40 mg/kg of LPPp for 10 or 20 days, respectively, and were followed by behavioral, hematological, biochemical and histopathological evaluation. Results showed no significant changes in body weight and organs of animals treated with LPPp. Total and differential blood leukocyte counts of LPPp groups did not differ from controls. There was no significant difference in aspartate aminotransferase, alanine aminotransferase, creatinine and urea measurements for the group treated for 20 days. The level of glutathione in the kidney was significantly higher in animals treated with LPPp in the acute toxicity test, but no differences were observed for the subchronic evaluation. The concentration of malondialdehyde and myeloperoxidase activity in the organs did not differ from controls. Histopathological examination of kidney, spleen and liver tissue of animals treated with LPPp revealed normal structures or reversible alterations. Intraperitoneal LD50 of LPPp was higher than 2,000 mg/kg. The data obtained reveal that LPPp is nontoxic at 40 mg/kg.